MedPath

DRM-02

Generic Name
DRM-02

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

Phase 2
Completed
Conditions
Psoriasis
Interventions
Other: Vehicle
First Posted Date
2013-11-25
Last Posted Date
2021-07-20
Lead Sponsor
Dermira, Inc.
Target Recruit Count
23
Registration Number
NCT01993433
Locations
🇨🇦

Clinique Médicale Dr Isabelle Delorme, Drummondville, Quebec, Canada

🇨🇦

Innovaderm Research, Inc, Montreal, Quebec, Canada

A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Other: Vehicle
First Posted Date
2013-11-25
Last Posted Date
2021-07-20
Lead Sponsor
Dermira, Inc.
Target Recruit Count
21
Registration Number
NCT01993420
Locations
🇨🇦

Clinique Médicale Dr Isabelle Delorme, Drummondville, Quebec, Canada

🇨🇦

Innovaderm Research, Inc, Montreal, Quebec, Canada

A Safety and Efficacy Study of DRM02 in Subjects With Rosacea

Phase 2
Completed
Conditions
Rosacea
Interventions
Other: Vehicle
First Posted Date
2013-11-25
Last Posted Date
2021-07-20
Lead Sponsor
Dermira, Inc.
Target Recruit Count
30
Registration Number
NCT01993446
Locations
🇨🇦

Windsor Clinical Research, Inc., Windsor, Ontario, Canada

🇨🇦

Clinique Médicale Dr Isabelle Delorme, Drummondville, Quebec, Canada

🇨🇦

Innovaderm Research, Inc, Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath